Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: A Prospective, Multicenter, Phase 2 Trial

Blood (2024) 144 (Supplement 1): 836.

https://doi.org/10.1182/blood-2024-208355

Published: 2024

Journal Articles

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: Interim Analysis of a Prospective, Multicenter, Phase 2 Trial

Shanshan Suo, Wen-Juan Yu, Ying Lu, Jiejing Qian, Liping Mao, Jin Wang, Lijing Shen, Bingzong Li, Huafeng Wang, Wenyuan MAI, Wanzhuo Xie, Xiaomin Wang, Dan Zhao, Yuanfang Liu, Chuan He, Jie Jin

Blood (2023) 142 (Supplement 1): 2869.

https://doi.org/10.1182/blood-2023-191190

Published: 2023

Journal Articles

PHF6 Maintains Acute Myeloid Leukemia Via Regulating NF-Κappab Signaling Pathway

Xiaomin Wang, Shuaibing Hou, Tengxiao Guo, Yanjie Lan, Shengnan Yuan, Shuang Yang, Fei Zhao, Yajing Chu, Cheng Tao, Weiping Yuan

Blood (2022) 140 (Supplement 1): 3003–3004.

https://doi.org/10.1182/blood-2022-155620

Published: 2022

Journal Articles

Factor X Activator for Hemophilia Patients with Inhibitors: A Phase 1, First-in-Human, Multi-Center, and Open-Label Trial

Wei Liu, Feng Xue, Rongfeng Fu, Bingjie Ding, Mengjuan Li, Ting Sun, Yunfei Chen, Liu Xiaofan, Mankai Ju, Xinyue Dai, Quanrui Wu, Zan Zhou, Xiaomin Wang, Jiaojiao Yu, Hu Zhou, Renchi Yang, Lei Zhang

Blood (2022) 140 (Supplement 1): 8474–8475.

https://doi.org/10.1182/blood-2022-159948

Published: 2022

Journal Articles

SETD5 Modulates Hematopoietic Stem Cells Homeostasis By Mediating RNA Polymerase II Pausing in Cooperation with HCF-1

Mengke Li, Yajing Chu, Chen Qiu, Yujie Bian, Deyang Shi, Bichen Wang, Qiuyi Ma, Xiaomin Wang, Jun Shi, Ping Zhu, Tao Cheng, Weiping Yuan

Blood (2021) 138 (Supplement 1): 22.

https://doi.org/10.1182/blood-2021-145830

Published: 2021

Journal Articles

PHF6 and JAK3 Mutations Cooperatively Drive T-Cell Acute Lymphoblastic Leukemia Progression

Xiaomin Wang, Shengnan Yuan, Shuaibing Hou, Yanjie Lan, Tengxiao Guo, Fei Zhao, Yajing Chu, Cheng Tao, Weiping Yuan

Blood (2021) 138 (Supplement 1): 783.

https://doi.org/10.1182/blood-2021-144386

Published: 2021

Journal Articles

CC-486 Mechanism Imparted By Extended Exposure of Azacitidine Upregulates Myeloid Differentiation Markers and Induces Cell Death in AML Cells

Diana R. Dunshee, Yumin Dai, Jessica C. Jang, Alberto Risueño, Danny V Jeyaraju, Patrick Hagner, PhD, Wendy L. See, Kyle MacBeth, Xiaomin Wang, Ignazia La Torre, Barry Skikne, MD, C.L. Beach, PharmD, Keshava Kumar, PhD, Anjan Thakurta, Daniel Lopes de Menezes, PhD

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-137606

Published: 2020

Journal Articles

RNA Binding Protein CELF2 Mutation Cooperates with MLL-AF9 in Driving Acute Myeloid Leukemia Development

Xiaomin Wang, Tengxiao Guo, Yuxia Wang, Shengnan Yuan, Shuaibing Hou, Yanjie Lan, Shuang Yang, Weiping Yuan, PhDMD

Blood (2020) 136 (Supplement 1): 3.

https://doi.org/10.1182/blood-2020-136538

Published: 2020

Journal Articles

Recombinant Human Thrombopoietin (rhTPO) and High-Dose Dexamethasone (HD-DXM) Versus High-Dose Dexamethasone Monotherapy As Frontline Treatment in Newly Diagnosed Adult Immune Thrombocytopenia (ITP): a Prospective, Multicentre, Randomised, Controlled Trial

Blood (2017) 130 (Supplement 1): 13.

https://doi.org/10.1182/blood.V130.Suppl_1.13.13

Published: 2017

Journal Articles

PBX3 is Essential for Leukemia Stem Cell Maintenance in MLL -Rearranged Leukemia

Huidong Guo, Yajing Chu, Le Wang, Hui Cheng, Weili Wang, Xiaomin Wang, Xiaobing Zhang, Tao Cheng, MD, Weiping Yuan, PhDMD

Blood (2016) 128 (22): 2694.

https://doi.org/10.1182/blood.V128.22.2694.2694

Published: 2016

Journal Articles

A Novel Approach to QTc Studies: Assessing Cardiac Safety of the mTOR Kinase Inhibitor CC-223 within the Dose-Escalation/Expansion Study

Robert B Kleiman, Rajesh Chopra, de Haan Hans, Kristen Hege, Angela J James, Xiaomin Wang, Xiaoling Wu, Edward O'Mara

Blood (2015) 126 (23): 5555.

https://doi.org/10.1182/blood.V126.23.5555.5555

Published: 2015

Journal Articles

PDK1 Controls the Differentiation of Hematopoietic Stem Cells Via Modulating ROS Levels

Tianyuan Hu, PhD, Cong Li, Le Wang, Yingchi Zhang, Luyun Peng, Weili Wang, Xiaomin Wang, Yajing Chu, Yingdai Gao, Bing Liu, Zhenyu Ju, Tao Cheng, MD, Weiping Yuan, PhDMD

Blood (2015) 126 (23): 896.

https://doi.org/10.1182/blood.V126.23.896.896

Published: 2015

Journal Articles

Interim Results of a Phase I Study of Lenalidomide (CC-5013) Plus Intraventricular/Intravenous Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma

James L. Rubenstein, MD, PhD, Paul Formaker, Xiaomin Wang, PhD, Nianhang Chen, PhD, Michael Seider, MD, Pamela Munster, MD, Bertil Damato, MD, PhD

Blood (2014) 124 (21): 4470.

https://doi.org/10.1182/blood.V124.21.4470.4470

Published: 2014

Journal Articles

Gadd45a regulates hematopoietic stem cell stress responses in mice

Yulin Chen, Xiaoming Ma, Meimei Zhang, Xiaomin Wang, Changxin Wang, Hu Wang, Peng Guo, Weiping Yuan, Karl Lenhard Rudolph, Qimin Zhan, Zhenyu Ju

Blood (2014) 123 (6): 851–862.

https://doi.org/10.1182/blood-2013-05-504084

Published: 2014

Includes: Supplemental data

Journal Articles

Evaluation Of CYP450 and Transporter-Mediated Drug-Drug Interaction Potential Of Pomalidomide In Healthy Men and In Vitro

Claudia Kasserra, PhD, Mahmoud Assaf, MS, MBA, Matthew Hoffmann, PhD, Yan Li, PhD, Liangang Liu, PhD, Xiaomin Wang, PhD, Gondi Kumar, PhD, Maria Palmisano, MD

Blood (2013) 122 (21): 1989.

https://doi.org/10.1182/blood.V122.21.1989.1989

Published: 2013

Journal Articles

Phase I Study Of P-Glycoprotein (P-gp) Mediated Drug Interactions Between Lenalidomide (LEN) and Quinidine Or Temsirolimus

Nianhang Chen, PhD, Daniel Weiss, MD, Josephine Reyes, DVM, Liangang Liu, PhD, Claudia Kasserra, PhD, Xiaomin Wang, PhD, Simon Zhou, PhD, Gondi Kumar, PhD, Lilia Weiss, MD, Maria Palmisano, MD

Blood (2013) 122 (21): 5395.

https://doi.org/10.1182/blood.V122.21.5395.5395

Published: 2013

Journal Articles

Pharmacokinetics (PK) of Lenalidomide When Administered Alone or in Combination with Dexamethasone in Chinese Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): The MM-021 Trial

Nianhang Chen, PhD, Dao-bin Zhou, MD, Li Yu, Jay Mei, MD, PhD, Liangang Liu, Xiaomin Wang, Honeylet Wortman-Vayn, Jian Hou, MD, PhD

Blood (2012) 120 (21): 5046.

https://doi.org/10.1182/blood.V120.21.5046.5046

Published: 2012

Journal Articles

Distinct Drug Responses of CD8 + CD4 + and CD8 + CD4 − leukemic Cell Subsets in Mice with Notch1-Induced T-ALL

Yingchi Zhang, Chunlan Hua, Hui Cheng, Weili Wang, Xiaomin Wang, Tao Cheng, MD, Weiping Yuan

Blood (2012) 120 (21): 1504.

https://doi.org/10.1182/blood.V120.21.1504.1504

Published: 2012

Journal Articles

CD44 is a phagocytic receptor

Eric Vachon, Raiza Martin, Jonathan Plumb, Vivian Kwok, R. William Vandivier, Michael Glogauer, Andras Kapus, Xiaomin Wang, Chung-Wai Chow, Sergio Grinstein, Gregory P. Downey

Blood (2006) 107 (10): 4149–4158.

https://doi.org/10.1182/blood-2005-09-3808

Published: 2006

NARROW

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: A Prospective, Multicenter, Phase 2 Trial

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: Interim Analysis of a Prospective, Multicenter, Phase 2 Trial

PHF6 Maintains Acute Myeloid Leukemia Via Regulating NF-Κappab Signaling Pathway

Factor X Activator for Hemophilia Patients with Inhibitors: A Phase 1, First-in-Human, Multi-Center, and Open-Label Trial

SETD5 Modulates Hematopoietic Stem Cells Homeostasis By Mediating RNA Polymerase II Pausing in Cooperation with HCF-1

PHF6 and JAK3 Mutations Cooperatively Drive T-Cell Acute Lymphoblastic Leukemia Progression

CC-486 Mechanism Imparted By Extended Exposure of Azacitidine Upregulates Myeloid Differentiation Markers and Induces Cell Death in AML Cells

RNA Binding Protein CELF2 Mutation Cooperates with MLL-AF9 in Driving Acute Myeloid Leukemia Development

Recombinant Human Thrombopoietin (rhTPO) and High-Dose Dexamethasone (HD-DXM) Versus High-Dose Dexamethasone Monotherapy As Frontline Treatment in Newly Diagnosed Adult Immune Thrombocytopenia (ITP): a Prospective, Multicentre, Randomised, Controlled Trial

PBX3 is Essential for Leukemia Stem Cell Maintenance in MLL -Rearranged Leukemia

A Novel Approach to QTc Studies: Assessing Cardiac Safety of the mTOR Kinase Inhibitor CC-223 within the Dose-Escalation/Expansion Study

PDK1 Controls the Differentiation of Hematopoietic Stem Cells Via Modulating ROS Levels

Interim Results of a Phase I Study of Lenalidomide (CC-5013) Plus Intraventricular/Intravenous Rituximab for Recurrent/Refractory CNS and Intraocular Lymphoma

Gadd45a regulates hematopoietic stem cell stress responses in mice

Evaluation Of CYP450 and Transporter-Mediated Drug-Drug Interaction Potential Of Pomalidomide In Healthy Men and In Vitro

Phase I Study Of P-Glycoprotein (P-gp) Mediated Drug Interactions Between Lenalidomide (LEN) and Quinidine Or Temsirolimus

Pharmacokinetics (PK) of Lenalidomide When Administered Alone or in Combination with Dexamethasone in Chinese Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): The MM-021 Trial

Distinct Drug Responses of CD8 + CD4 + and CD8 + CD4 − leukemic Cell Subsets in Mice with Notch1-Induced T-ALL

CD44 is a phagocytic receptor

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only